Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma

Research output: Contribution to journal › Article › Academic › peer-review

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{944c67056b53419f88993cec2476e39c,

title = "Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma",

author = "Smit, \{J. W.\} and \{van Tol\}, \{K. M.\} and Hew, \{J. M.\} and Vielvoye, \{G. J.\} and Romijn, \{J. A.\} and Links, \{T. P.\}",

year = "2001",

doi = "10.1046/j.1365-2265.2001.01337.x",

language = "English",

volume = "55",

pages = "421--422",

journal = "Clinical endocrinology",

issn = "0300-0664",

publisher = "Wiley Blackwell",

number = "3",

}

TY - JOUR

T1 - Marimastat therapy as adjuvant to selective embolization in skeletal metastases of differentiated thyroid carcinoma

AU - Smit, J. W.

AU - van Tol, K. M.

AU - Hew, J. M.

AU - Vielvoye, G. J.

AU - Romijn, J. A.

AU - Links, T. P.

PY - 2001

Y1 - 2001

U2 - 10.1046/j.1365-2265.2001.01337.x

DO - 10.1046/j.1365-2265.2001.01337.x

M3 - Article

C2 - 11589688

SN - 0300-0664

VL - 55

SP - 421

EP - 422

JO - Clinical endocrinology

JF - Clinical endocrinology

IS - 3

ER -